Skip to main content
logo
Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
201.20
-1.40 (-0.69%)
Aug 11, 2026, 2:58 PM HKT

HKG:2637 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
582.36582.36466.68316.63212.47
Revenue Growth
-24.79%47.39%49.03%-
Gross Profit
485.56485.56387.19263.64172.07
Operating Income
192.26192.26133.03120.2880.35
Net Income
177.03177.03136.08117.4568.98
Earnings Per Share
2.552.552.021.751.07
EPS Growth
-25.79%15.86%62.83%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
1,3301,330273.24274.6312.17
Total Debt
110.15110.1556.8850.0992.18
Net Cash (Debt)
1,2201,220216.36224.51219.99
Net Cash Growth
-464.03%-3.63%2.05%-
Net Cash Per Share
17.5617.563.223.343.42

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
159.88159.88163.94147.1185.31
Capital Expenditures
-44.79-44.79-178.56-58.71-3.07
Free Cash Flow
115.09115.09-14.6288.3982.24
Free Cash Flow Growth
---7.47%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
83.38%83.38%82.97%83.26%80.99%
Operating Margin
33.01%33.01%28.51%37.99%37.82%
Pretax Margin
34.01%34.01%31.93%41.95%34.72%
Profit Margin
30.40%30.40%29.16%37.09%32.47%
FCF Margin
19.76%19.76%-3.13%27.92%38.71%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
71.4854.34---
P/FCF Ratio
124.5183.58---
PS Ratio
24.6116.52---